image
Corvus Pharmaceuticals, Inc. CRVS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.065
4.27 %
$ 313 M
Market Cap
-3.8
P/E
Price Target Average
195.20%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
25.27%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Corvus Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for CRVS of $12 , with forecasts ranging from a low of $11 to a high of $13 .
CRVS Lowest Price Target Wall Street Target
11 USD 170.60%
CRVS Average Price Target Wall Street Target
12 USD 195.20%
CRVS Highest Price Target Wall Street Target
13 USD 219.80%
Price
Max Price Target
Min Price Target
Average Price Target
1414121210108866442200Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart CRVS

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CRVS

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CRVS

image
$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)20232023202420242025202520262026202720272028202820292029